Pharmacy Medical News about Phase II Study

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A Comparison of Phase II Study Strategies
Clinical Cancer Research, 10/01/09

Hunsberger S et al. – In this article, the authors compare different phase II study strategies to determine the most efficient drug development path in terms of number of patients and length of time to conclusion of drug efficacy on overall survival.

<< Previous
Large-Scale Sequence Analysis of M Gene of Influenza A Viruses...

Next >>
Reduced Occipital and Prefrontal Brain Volumes in...

Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma
American Journal of Clinical Oncology, 10/06/09 Relevance Score: 81%

Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes
Annals of Oncology, 11/17/09 Relevance Score: 80%

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 10/29/09 Relevance Score: 80%

Effect of timing on the outcomes of 1-phase nonextraction therapy of Class II malocclusion
American Journal of Orthodontics and Dentofacial Orthopedics, 10/29/09 Relevance Score: 80%

Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
British Journal of Cancer, 10/19/09 Relevance Score: 80%